Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2023

Open Access 01-12-2023 | Research

Effect of open versus video-assisted thoracoscopy on perioperative outcomes and survival for cases of thymic carcinomas and thymic neuroendocrine tumors

Authors: Gaiyan Li, Hao Chang, Zhuangzhuang Wang, Dongjie He, Lin Qu, Qiuju Shao, Qiming Wang

Published in: World Journal of Surgical Oncology | Issue 1/2023

Login to get access

Abstract

Background

The oncology-related indices between open and video-assisted thoracoscopic surgery (VATS) procedures for thymic carcinomas (TCs) and thymic neuroendocrine tumors (TNETs) remain unclear.

Methods

Propensity score matching (PSM) and multivariate Cox proportional risk models were used to evaluate the perioperative outcomes and survival rates of patients undergoing open and VATS for TCs and TNETs at the Second Affiliated Hospital of Air Force Military Medical University Hospital, between 2009 and 2018.

Results

Of the total 126 cases of TCs and TNETs, VATS treatment was used in 39 (30.9%). Advanced age and Masaoka-Koga staging were found to be independent prognostic factors for both TCs and TNETs, through a multifactorial Cox regression analysis. There was no significant difference in survival between the VATS and open groups before and after PSM; however, the VATS group had better perioperative-related indicators. There were no significant differences between the groups in terms of mortality at 30 days, mortality at 90 days, R0 resection rate, and 5-year survival rate (67.5% vs. 58.5% [P = 0.260] in the VATS group compared to the open group, in a PSM analysis of the 27 VATS and 27 open groups). Compared to the open group, the VATS group had a shorter length of hospital stay (13 days vs. 16 days, P = 0.015), a shorter level I care (0 days vs. 1 day, P = 0.016), and less intraoperative bleeding (50 mL vs. 300 mL, P < 0.001).

Conclusions

In this single-center retrospective study of TCs and TNETs, survival rates were comparable between the VATS group and the open group, and the VATS group showed improved perioperative-related parameters.
Appendix
Available only for authorised users
Literature
1.
go back to reference Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, et al. The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors? J Thorac Oncol. 2022;17:200–13.CrossRefPubMed Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, et al. The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors? J Thorac Oncol. 2022;17:200–13.CrossRefPubMed
2.
go back to reference Ahmad U, Yao X, Detterbeck F, Huang J, Antonicelli A, Filosso PL, et al. Thymic carcinoma outcomes and prognosis: results of an international analysis. J Thorac Cardiovasc Surg. 2015;149:95–100. 101.e1 2.CrossRefPubMed Ahmad U, Yao X, Detterbeck F, Huang J, Antonicelli A, Filosso PL, et al. Thymic carcinoma outcomes and prognosis: results of an international analysis. J Thorac Cardiovasc Surg. 2015;149:95–100. 101.e1 2.CrossRefPubMed
4.
go back to reference Koizumi T, Otsuki K, Tanaka Y, Noguchi T, Fukushuima T, Kobayashi T, et al. National incidence and initial therapy for thymic carcinoma in Japan: based on analysis of hospital-based cancer registry data, 2009–2015. Jpn J Clin Oncol. 2020;50:434–9.CrossRefPubMed Koizumi T, Otsuki K, Tanaka Y, Noguchi T, Fukushuima T, Kobayashi T, et al. National incidence and initial therapy for thymic carcinoma in Japan: based on analysis of hospital-based cancer registry data, 2009–2015. Jpn J Clin Oncol. 2020;50:434–9.CrossRefPubMed
5.
go back to reference Li W, Miao Z, Liu X, Zhang Q, Sun L, Li P, et al. Thymic carcinoma patients with myasthenia gravis exhibit better prognoses. Int J Clin Oncol. 2016;21:75–80.CrossRefPubMed Li W, Miao Z, Liu X, Zhang Q, Sun L, Li P, et al. Thymic carcinoma patients with myasthenia gravis exhibit better prognoses. Int J Clin Oncol. 2016;21:75–80.CrossRefPubMed
6.
go back to reference Fu H, Gu Z-T, Fang W-T, Fu J-H, Shen Y, Han Y-T, et al. Long-term survival after surgical treatment of thymic carcinoma: a retrospective analysis from the chinese alliance for research of thymoma database. Ann Surg Oncol. 2016;23:619–25.CrossRefPubMed Fu H, Gu Z-T, Fang W-T, Fu J-H, Shen Y, Han Y-T, et al. Long-term survival after surgical treatment of thymic carcinoma: a retrospective analysis from the chinese alliance for research of thymoma database. Ann Surg Oncol. 2016;23:619–25.CrossRefPubMed
7.
go back to reference Hwang SK, Lee GD, Kang CH, Cho JH, Choi YS, Lee JG, et al. Long-term outcome of minimally invasive thymectomy versus open thymectomy for locally advanced cases. Eur J Cardiothorac Surg. 2022;62:ezac238.CrossRefPubMed Hwang SK, Lee GD, Kang CH, Cho JH, Choi YS, Lee JG, et al. Long-term outcome of minimally invasive thymectomy versus open thymectomy for locally advanced cases. Eur J Cardiothorac Surg. 2022;62:ezac238.CrossRefPubMed
8.
go back to reference Kamel MK, Villena-Vargas J, Rahouma M, Lee B, Harrison S, Stiles BM, et al. National trends and perioperative outcomes of robotic resection of thymic tumours in the United States: a propensity matching comparison with open and video-assisted thoracoscopic approaches†. Eur J Cardiothorac Surg. 2019;56:762–9.CrossRefPubMed Kamel MK, Villena-Vargas J, Rahouma M, Lee B, Harrison S, Stiles BM, et al. National trends and perioperative outcomes of robotic resection of thymic tumours in the United States: a propensity matching comparison with open and video-assisted thoracoscopic approaches†. Eur J Cardiothorac Surg. 2019;56:762–9.CrossRefPubMed
9.
go back to reference Ruffini E, Filosso PL, Guerrera F, Lausi P, Lyberis P, Oliaro A. Optimal surgical approach to thymic malignancies: new trends challenging old dogmas. Lung Cancer. 2018;118:161–70.CrossRefPubMed Ruffini E, Filosso PL, Guerrera F, Lausi P, Lyberis P, Oliaro A. Optimal surgical approach to thymic malignancies: new trends challenging old dogmas. Lung Cancer. 2018;118:161–70.CrossRefPubMed
10.
go back to reference Cheng Y-J. Videothoracoscopic resection of encapsulated thymic carcinoma: retrospective comparison of the results between thoracoscopy and open methods. Ann Surg Oncol. 2008;15:2235–8.CrossRefPubMed Cheng Y-J. Videothoracoscopic resection of encapsulated thymic carcinoma: retrospective comparison of the results between thoracoscopy and open methods. Ann Surg Oncol. 2008;15:2235–8.CrossRefPubMed
11.
go back to reference Hurd J, Haridas C, Potter A, Baiu I, Beqari J, Deng J, et al. A national analysis of open versus minimally invasive thymectomy for stage I-III thymic carcinoma. Eur J Cardiothorac Surg. 2022;9:ezac159.CrossRef Hurd J, Haridas C, Potter A, Baiu I, Beqari J, Deng J, et al. A national analysis of open versus minimally invasive thymectomy for stage I-III thymic carcinoma. Eur J Cardiothorac Surg. 2022;9:ezac159.CrossRef
13.
go back to reference Falkson CB, Vella ET, Ellis PM, Maziak DE, Ung YC, Yu E. Surgical, radiation, and systemic treatments of patients with thymic epithelial tumours: a clinical practice guideline. J Thorac Oncol. 2022;S1556-0864(22)01542-8. Falkson CB, Vella ET, Ellis PM, Maziak DE, Ung YC, Yu E. Surgical, radiation, and systemic treatments of patients with thymic epithelial tumours: a clinical practice guideline. J Thorac Oncol. 2022;S1556-0864(22)01542-8.
14.
go back to reference Roden AC, Fang W, Shen Y, Carter BW, White DB, Jenkins SM, et al. Distribution of mediastinal lesions across multi-institutional, international, radiology databases. J Thorac Oncol. 2020;15:568–79.CrossRefPubMed Roden AC, Fang W, Shen Y, Carter BW, White DB, Jenkins SM, et al. Distribution of mediastinal lesions across multi-institutional, international, radiology databases. J Thorac Oncol. 2020;15:568–79.CrossRefPubMed
15.
go back to reference Roden AC, Yi ES, Cassivi SD, Jenkins SM, Garces YI, Aubry MC. Clinicopathological features of thymic carcinomas and the impact of histopathological agreement on prognostical studies. Eur J Cardiothorac Surg. 2013;43:1131–9.CrossRefPubMed Roden AC, Yi ES, Cassivi SD, Jenkins SM, Garces YI, Aubry MC. Clinicopathological features of thymic carcinomas and the impact of histopathological agreement on prognostical studies. Eur J Cardiothorac Surg. 2013;43:1131–9.CrossRefPubMed
16.
go back to reference Hishida T, Nomura S, Yano M, Asamura H, Yamashita M, Ohde Y, et al. Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study. Eur J Cardiothorac Surg. 2016;49:835–41.CrossRefPubMed Hishida T, Nomura S, Yano M, Asamura H, Yamashita M, Ohde Y, et al. Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study. Eur J Cardiothorac Surg. 2016;49:835–41.CrossRefPubMed
17.
go back to reference Litvak AM, Woo K, Hayes S, Huang J, Rimner A, Sima CS, et al. Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging. J Thorac Oncol. 2014;9:1810–5.CrossRefPubMedPubMedCentral Litvak AM, Woo K, Hayes S, Huang J, Rimner A, Sima CS, et al. Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging. J Thorac Oncol. 2014;9:1810–5.CrossRefPubMedPubMedCentral
18.
go back to reference Liu H-C, Hsu W-H, Chen Y-J, Chan Y-J, Wu Y-C, Huang B-S, et al. Primary thymic carcinoma. Ann Thorac Surg. 2002;73:1076–81. Liu H-C, Hsu W-H, Chen Y-J, Chan Y-J, Wu Y-C, Huang B-S, et al. Primary thymic carcinoma. Ann Thorac Surg. 2002;73:1076–81.
19.
go back to reference Hosaka Y, Tsuchida M, Toyabe S, Umezu H, Eimoto T, Hayashi J. Masaoka stage and historical grade predictive diagnosis in patients with thyroid cancer Ann Thorac Surg. 2010;89:912-7. Hosaka Y, Tsuchida M, Toyabe S, Umezu H, Eimoto T, Hayashi J. Masaoka stage and historical grade predictive diagnosis in patients with thyroid cancer Ann Thorac Surg. 2010;89:912-7.
20.
go back to reference Hosaka Y, Tsuchida M, Toyabe S, Umezu H, Eimoto T, Hayashi J. Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma. Ann Thorac Surg. 2010;89:912–7.CrossRefPubMed Hosaka Y, Tsuchida M, Toyabe S, Umezu H, Eimoto T, Hayashi J. Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma. Ann Thorac Surg. 2010;89:912–7.CrossRefPubMed
21.
go back to reference Chalabreysse L, Etienne-Mastroianni B, Adeleine P, Cordier J-F, Greenland T, Thivolet-Bejui F. Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases. Histopathology. 2004;44:367–74.CrossRefPubMed Chalabreysse L, Etienne-Mastroianni B, Adeleine P, Cordier J-F, Greenland T, Thivolet-Bejui F. Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases. Histopathology. 2004;44:367–74.CrossRefPubMed
22.
go back to reference Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W, et al. Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. J Thorac Oncol. 2014;9:541–8.CrossRefPubMed Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W, et al. Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. J Thorac Oncol. 2014;9:541–8.CrossRefPubMed
23.
go back to reference Jackson MW, Palma DA, Camidge DR, Jones BL, Robin TP, Sher DJ, et al. The impact of postoperative radiotherapy for thymoma and thymic carcinoma. J Thorac Oncol. 2017;12:734–44.CrossRefPubMed Jackson MW, Palma DA, Camidge DR, Jones BL, Robin TP, Sher DJ, et al. The impact of postoperative radiotherapy for thymoma and thymic carcinoma. J Thorac Oncol. 2017;12:734–44.CrossRefPubMed
24.
go back to reference Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S, ESMO Guidelines Committee. Thymic epithelial tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;5:v40-55.CrossRef Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S, ESMO Guidelines Committee. Thymic epithelial tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;5:v40-55.CrossRef
25.
go back to reference Cho J, Kim HS, Ku BM, Choi Y-L, Cristescu R, Han J, et al. Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial. J Clin Oncol. 2019;37:2162–70.CrossRefPubMed Cho J, Kim HS, Ku BM, Choi Y-L, Cristescu R, Han J, et al. Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial. J Clin Oncol. 2019;37:2162–70.CrossRefPubMed
26.
go back to reference Giaccone G, Kim C. Durable Response in Patients With Thymic Carcinoma Treated With Pembrolizumab After Prolonged Follow-Up. J Thorac Oncol. 2021;16:483–5. Giaccone G, Kim C. Durable Response in Patients With Thymic Carcinoma Treated With Pembrolizumab After Prolonged Follow-Up. J Thorac Oncol. 2021;16:483–5.
28.
go back to reference Zhao Y, Gu H, Fan L, Han K, Yang J, Zhao H. Comparison of clinical features and survival between thymic carcinoma and thymic carcinoid patients. Eur J Cardiothorac Surg. 2017;52:33–8.CrossRefPubMed Zhao Y, Gu H, Fan L, Han K, Yang J, Zhao H. Comparison of clinical features and survival between thymic carcinoma and thymic carcinoid patients. Eur J Cardiothorac Surg. 2017;52:33–8.CrossRefPubMed
Metadata
Title
Effect of open versus video-assisted thoracoscopy on perioperative outcomes and survival for cases of thymic carcinomas and thymic neuroendocrine tumors
Authors
Gaiyan Li
Hao Chang
Zhuangzhuang Wang
Dongjie He
Lin Qu
Qiuju Shao
Qiming Wang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2023
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-023-03210-7

Other articles of this Issue 1/2023

World Journal of Surgical Oncology 1/2023 Go to the issue